Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)

Market Cap	75.11B -21.0%
Revenue (ttm)	13.98B +18.1%
Net Income	2.35B +1.1%
EPS	6.71 +1.1%
Shares Out	350.00M
PE Ratio	31.99
Forward PE	28.65
Dividend	4.83 (2.24%)
Ex-Dividend Date	May 10, 2026

Volume	367,488
Open	215.30
Previous Close	215.30
Day's Range	213.70 - 218.00
52-Week Range	211.50 - 281.20
Beta	0.05
Analysts	Buy
Price Target	274.11 (+27.73%)
Earnings Date	Jul 30, 2026

About TADAWUL:4013

Dr. Sulaiman Al Habib Medical Services Group Company, together with its subsidiaries, provides private health and support services in the Kingdom of Saudi Arabia. It operates through three segments: Hospitals/Healthcare Facilities, Pharmacies, and Other Solutions Sector. The company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, and pharmaceutical facilities. It also provides home medical care; specialized medical laboratories; information technology and systems; facility maintenanc...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1993
• Employees: 10,475
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4013

Financial Performance

In 2025, TADAWUL:4013's revenue was 13.71 billion, an increase of 22.38% compared to the previous year's 11.20 billion. Earnings were 2.40 billion, an increase of 3.72%.

Analyst Summary

According to 14 analysts, the average rating for 4013 stock is "Buy." The 12-month stock price target is SAR 274.11, which is an increase of 27.73% from the latest price.

Price Target

SAR 274.11

(27.73% upside)

Analyst Consensus: Buy